Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isodiol Intl | OTC Markets | Healthcare | Pharmaceuticals | USD 12.85K | 0x | USD 0.00010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Herborium | OTC Markets | Healthcare | Biotechnology & Medical Research | USD 1.09M | 0x | USD 0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Zhuding | OTC Markets | Industrials | Professional & Commercial Services | USD 1.94M | -0x | USD 0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DeFi Tech | OTC Markets | Financial | Banking Services | USD 580.75M | 12.3x | 0.06 | USD 1.99 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SolarWindow Tech | OTC Markets | Energy | Renewable Energy | USD 14.52M | -4.3x | 0.13 | USD 0.27 | -19.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acura Pharma | OTC Markets | Healthcare | Biotechnology & Medical Research | USD 331.75K | -0.1x | USD 0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | USD 8.05B | -22.5x | 0.52 | USD 29.24 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Fastbase | OTC Markets | Technology | Software & IT Services | USD 9.76M | USD 0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Itokk | OTC Markets | Financial | Investment Holding Companies | USD 353.44K | USD 0.0007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Labor Smart Inc | OTC Markets | Industrials | Professional & Commercial Services | USD 45.30M | USD 0.003 | -12.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ADMA Biologics Inc | NASDAQ | Healthcare | Pharmaceuticals | USD 4.30B | 120.9x | 0.68 | USD 18.47 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
LianBio ADR | OTC Markets | Healthcare | Biotechnology & Medical Research | USD 38.61M | -5.1x | -0.02 | USD 0.36 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AKA Brands Holding | NYSE | Consumer Cyclicals | Specialty Retailers | USD 266.57M | -1.8x | -0.06 | USD 28.99 | 14.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -20.9% Downside | Upgrade to Pro+ | |
South Beach Spirits | OTC Markets | Real Estate | Real Estate Operations | USD 2.47M | -1.1x | USD 0 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
KYN Capital | OTC Markets | Technology | Software & IT Services | USD 6.52M | -0x | USD 0.0009 | -18.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lendingtree | NASDAQ | Financial | Banking Services | USD 766.54M | -5.9x | -0.3 | USD 57.37 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
FTAI Aviation | NASDAQ | Financial | Banking Services | USD 13B | -237.7x | 1.3 | USD 127.18 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Casi Pharma | NASDAQ | Healthcare | Pharmaceuticals | USD 109.78M | -3.6x | -0.12 | USD 7.30 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.3% Downside | Upgrade to Pro+ | |
Blend Labs | NYSE | Technology | Software & IT Services | USD 972.48M | -7.8x | -0.13 | USD 3.81 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13% Downside | Upgrade to Pro+ | |
Red Cat Holdings | NASDAQ | Industrials | Aerospace & Defense | USD 224.42M | -7.5x | -0.47 | USD 2.99 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.7% Upside | Upgrade to Pro+ | |
Giant Motorsports | OTC Markets | Consumer Cyclicals | Specialty Retailers | USD 8.02M | -75x | USD 0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CervoMed | NASDAQ | Healthcare | Biotechnology & Medical Research | USD 139.74M | -20.5x | USD 16.93 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Identa | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | USD 2.25M | 3.2x | USD 0.56 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Yuenglings Ice Cream | OTC Markets | Technology | Software & IT Services | USD 2.41M | -2.5x | USD 0.004 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Tutor Perini | NYSE | Industrials | Construction & Engineering | USD 1.24B | -18.4x | -0.27 | USD 23.80 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Vitalhub | OTC Markets | Healthcare | Healthcare Equipment & Supplies | USD 328.90M | 83.9x | 0.11 | USD 6.49 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aquestive Therapeutics | NASDAQ | Healthcare | Pharmaceuticals | USD 455.30M | -14.3x | -1.17 | USD 4.99 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Entera Bio | NASDAQ | Healthcare | Biotechnology & Medical Research | USD 70.83M | -7.6x | -0.28 | USD 1.95 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C4 | NASDAQ | Healthcare | Biotechnology & Medical Research | USD 435.44M | -3.5x | -0.11 | USD 6.29 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Praxis Precision | NASDAQ | Healthcare | Biotechnology & Medical Research | USD 1.05B | -6.1x | -0.11 | USD 58.97 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |